PE firm goes in for image makeover, appoints advisory group.
"In the backdrop of inadequate disclosure levels on share pledging, investment in such companies exposes an investor to severe price volatility in case a promoter is not able to meet payments or provide additional collaterals in a falling market," analysts at Crisil Equities said in a research report.
Indian pharmaceutical companies, which always wanted a big share in the global copycat drug market, are betting high on the oral contraceptive (OC) market in America.
Its first and only investment in India out of its Asia-dedicated fund has gone bad.
Products structured on real estate and promising over 20 per cent annual returns are gaining popularity among wealthy investors.
Till October 14 this year, FIIs were net sellers in equities at Rs 1,132 crore (Rs 11.32 billion) while their debt exposure stood at Rs 20,029 crore (Rs 200.29 billion). This is the first time since 2008 that FIIs are net sellers in equities.
The Burman family is in talks to buy less than 26 per cent stake in Espirito Santo India.
Hilton's inspiring personal memoir seems to have inspired sons of India's top corporate honchos. Only they are not following in their fathers' footsteps to make their presence felt.
Tapping opportunities in this growing industry, major players are expanding their business and raising funds through the public market or private equity route.
Samina Vaziralli, daughter of joint Managing Director M K Hamied, was inducted into the company management. Cipla joins the league of major companies such as Lupin, Wockhardt, Elder Pharma, Piramal Healthcare and JB Chemicals in this regard.
According to market sources, Jhunjhunwala will acquire a significant minority stake in Pipavav.
It may be Doktor Mom in Russia, or Farex in India.
Milestone was in an aggressive mode, by hiring more senior people to head its funds and launching new funds.
Minority shareholders are disappointed after the Securities and Exchange Board of India (Sebi) increased the size of the mandatory open offer from 20 per cent to 26 per cent, ignoring the Achuthan panel's recommendation of giving all shareholders an exit option.
Both the main stock exchanges have set in motion a separate platform to generate more interest and more liquidity for the small and medium enterprises (SME) segment.
The saga of buying out high-end office space in Mumbai continues. In a latest development, Mumbai-based education company, Core Projects and Technologies, is in talks with the leading plastic goods maker Supreme Industries to buy out the office property developed by the latter in the Andheri area of Mumbai. The deal could be worth Rs 350 crore (Rs 3.5 billion) in value, said sources close to the development.
Providence had bought 15 per cent in Idea Cellular in 2006 for around Rs 1,800 crore (Rs 18 billion) through its investment arm - P5 Asia Investment (Mauritius).
"The tacit understanding between people now is that a question should be looked upon as a statement," says an institutional dealer.
Rupee-denominated contracts will be traded from 9 am to 5 pm.
Six months after the Paras deal, Actis wants to exit Sterling Hospitals, a Gujarat-based multi-speciality hospital chain with six centres, according to three independent sources in the know.
© 2025 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances